open access

Vol 2, No 2 (2017)
CASE REPORTS
Published online: 2017-06-28
Get Citation

Intravitreal anti-VEGF therapy in macular oedema secondary to racemose haemangiomatosis of the retina

Magdalena Tylus, Jerzy Mackiewicz, Joanna Dolar-Szczasny, Anna Święch-Zubilewicz
DOI: 10.5603/OJ.2017.0014
·
Ophthalmology J 2017;2(2):58-60.

open access

Vol 2, No 2 (2017)
CASE REPORTS
Published online: 2017-06-28

Abstract

Racemose haemangiomatosis of the retina is a sporadic, mostly unilateral, congenital arteriovenous malformation (AVM), comprising abnormal junctions between arteries and veins that omit capillaries. Typically, vascular malformations are asymptomatic and incidentally discovered. Advanced changes may be related to the presence of subretinal fluid and exudates, even though these lesions are classified as benign. Many complications can lead to severe or permanent visual impairment. Direct methods of treatment of primary retinal vascular anomalies have not been developed yet. The aim of this case report is to present the anti-VEGF therapy in the treatment macular oedema secondary to racemose haemangioma.

Abstract

Racemose haemangiomatosis of the retina is a sporadic, mostly unilateral, congenital arteriovenous malformation (AVM), comprising abnormal junctions between arteries and veins that omit capillaries. Typically, vascular malformations are asymptomatic and incidentally discovered. Advanced changes may be related to the presence of subretinal fluid and exudates, even though these lesions are classified as benign. Many complications can lead to severe or permanent visual impairment. Direct methods of treatment of primary retinal vascular anomalies have not been developed yet. The aim of this case report is to present the anti-VEGF therapy in the treatment macular oedema secondary to racemose haemangioma.

Get Citation

Keywords

racemose haemangiomatosis, anti-VEGF, macular oedema, intravitreal injection

About this article
Title

Intravitreal anti-VEGF therapy in macular oedema secondary to racemose haemangiomatosis of the retina

Journal

Ophthalmology Journal

Issue

Vol 2, No 2 (2017)

Pages

58-60

Published online

2017-06-28

DOI

10.5603/OJ.2017.0014

Bibliographic record

Ophthalmology J 2017;2(2):58-60.

Keywords

racemose haemangiomatosis
anti-VEGF
macular oedema
intravitreal injection

Authors

Magdalena Tylus
Jerzy Mackiewicz
Joanna Dolar-Szczasny
Anna Święch-Zubilewicz

References (16)
  1. Turell ME, Singh AD. Vascular tumors of the retina and choroid: diagnosis and treatment. Middle East Afr J Ophthalmol. 2010; 17(3): 191–200.
  2. Knutsson KA, De Benedetto U, Querques G, et al. Primitive retinal vascular abnormalities: tumors and telangiectasias. Ophthalmologica. 2012; 228(2): 67–77.
  3. Wyburn-Mason R. Arteriovenous aneurysm of midbrain and retina, facial, nevi and mental changes. Brain. 1943; 66(3): 163–203.
  4. Théron J, Newton TH, Hoyt WF. Unilateral retinocephalic vascular malformations. Neuroradiology. 1974; 7(4): 185–196.
  5. Szaflik J, Starzycka M. Patologia narządu wzroku i guzy wewnątrzgałkowe. Seria Basic and Clinical Science Course (BCSC 4). Urban&Partner, Wrocław 2003: 263.
  6. Archer DB, Deutman A, Ernest JT, et al. Arteriovenous communications of the retina. Am J Ophthalmol. 1973; 75(2): 224–241.
  7. Heimann H, Jmor F, Damato B. Imaging of retinal and choroidal vascular tumours. Eye (Lond). 2013; 27(2): 208–216.
  8. Kenawy N, Groenwald C, Damato B. Treatment of a vasoproliferative tumour with intravitreal bevacizumab (Avastin). Eye (Lond). 2007; 21(6): 893–894.
  9. Shah GK, Shields JA, Lanning RC. Branch retinal vein obstruction secondary to retinal arteriovenous communication. Am J Ophthalmol. 1998; 126(3): 446–448.
  10. Qin Xj, Huang C, Lai K. Retinal vein occlusion in retinal racemose hemangioma: a case report and literature review of ocular complications in this rare retinal vascular disorder. BMC Ophthalmol. 2014; 14: 101.
  11. Panagiotidis D, Karagiannis D, Tsoumpris I. Spontaneous development of macular ischemia in a case of racemose hemangioma. Clin Ophthalmol. 2011; 5: 931–932.
  12. Effron L, Zakov ZN, Tomsak RL. Neovascular glaucoma as a complication of the Wyburn-Mason syndrome. J Clin Neuroophthalmol. 1985; 5(2): 95–98.
  13. Sanfilippo CJ, Sarraf D. Congenital macrovessel associated with cystoid macular edema and an ipsilateral intracranial venous malformation. Retin Cases Brief Rep. 2015; 9(4): 357–359.
  14. Onder HI, Alisan S, Tunc M. Serous retinal detachment and cystoid macular edema in a patient with Wyburn-Mason syndrome. Semin Ophthalmol. 2015; 30(2): 154–156.
  15. Soliman W, Haamann P, Larsen M. Exudation, response to photocoagulation and spontaneous remission in a case of bilateral racemose haemangioma. Acta Ophthalmol Scand. 2006; 84(3): 429–431.
  16. Winter E, Elsås T, Austeng D. Anti-VEGF treating macular oedema caused by retinal arteriovenous malformation - a case report. Acta Ophthalmol. 2014; 92(2): 192–193.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl